Electron beam tomography in women

Is it a valuable test?

Khurram Nasir, Paolo Raggi, John A. Rumberger, Matthew J. Budoff, Roger S Blumenthal

Research output: Contribution to journalArticle

Abstract

Cardiovascular disease (CVD) is the leading cause of mortality in women and a major cause of morbidity. Coronary artery disease (CAD) accounts for nearly half of all CVD deaths. Traditional risk factors are very helpful in predicting the development of CAD in women; however, many women suffer events in the absence of established risk factors for atherosclerosis. To meet the challenge of CAD, several tools have been developed to identify atherosclerotic disease in its preclinical stages, with the hope of modifying its natural history. In this article, we review the current literature on utilization of electron beam tomography (EBT) for detection of CAD as a tool to conduct risk stratification in the general asymptomatic female population as well as among asymptomatic women. In conclusion, EBT can be used to estimate the overall coronary atherosclerotic plaque burden in women. It can also be used to diagnose its presence and determine its extent; furthermore, information from the coronary artery calcium scores can be used to assess the likelihood of obstructive disease and to provide prognostic information. Finally, EBT has the potential to determine the consequences of therapeutic interventions regarding progression, stabilization, or regression of coronary atherosclerotic disease.

Original languageEnglish (US)
Pages (from-to)174-183
Number of pages10
JournalCardiology in Review
Volume13
Issue number4
DOIs
StatePublished - Jul 2005

Fingerprint

X Ray Computed Tomography
Coronary Artery Disease
Cardiovascular Diseases
Atherosclerotic Plaques
Natural History
Coronary Disease
Atherosclerosis
Coronary Vessels
Calcium
Morbidity
Mortality
Population

Keywords

  • Calcification
  • Coronary artery disease
  • Electron beam tomography
  • Prevention
  • Women

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Electron beam tomography in women : Is it a valuable test? / Nasir, Khurram; Raggi, Paolo; Rumberger, John A.; Budoff, Matthew J.; Blumenthal, Roger S.

In: Cardiology in Review, Vol. 13, No. 4, 07.2005, p. 174-183.

Research output: Contribution to journalArticle

Nasir, Khurram ; Raggi, Paolo ; Rumberger, John A. ; Budoff, Matthew J. ; Blumenthal, Roger S. / Electron beam tomography in women : Is it a valuable test?. In: Cardiology in Review. 2005 ; Vol. 13, No. 4. pp. 174-183.
@article{c0c8b5b2746c435790d575d7035820e0,
title = "Electron beam tomography in women: Is it a valuable test?",
abstract = "Cardiovascular disease (CVD) is the leading cause of mortality in women and a major cause of morbidity. Coronary artery disease (CAD) accounts for nearly half of all CVD deaths. Traditional risk factors are very helpful in predicting the development of CAD in women; however, many women suffer events in the absence of established risk factors for atherosclerosis. To meet the challenge of CAD, several tools have been developed to identify atherosclerotic disease in its preclinical stages, with the hope of modifying its natural history. In this article, we review the current literature on utilization of electron beam tomography (EBT) for detection of CAD as a tool to conduct risk stratification in the general asymptomatic female population as well as among asymptomatic women. In conclusion, EBT can be used to estimate the overall coronary atherosclerotic plaque burden in women. It can also be used to diagnose its presence and determine its extent; furthermore, information from the coronary artery calcium scores can be used to assess the likelihood of obstructive disease and to provide prognostic information. Finally, EBT has the potential to determine the consequences of therapeutic interventions regarding progression, stabilization, or regression of coronary atherosclerotic disease.",
keywords = "Calcification, Coronary artery disease, Electron beam tomography, Prevention, Women",
author = "Khurram Nasir and Paolo Raggi and Rumberger, {John A.} and Budoff, {Matthew J.} and Blumenthal, {Roger S}",
year = "2005",
month = "7",
doi = "10.1097/01.crd.0000151371.92623.5c",
language = "English (US)",
volume = "13",
pages = "174--183",
journal = "Cardiology in Review",
issn = "1061-5377",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Electron beam tomography in women

T2 - Is it a valuable test?

AU - Nasir, Khurram

AU - Raggi, Paolo

AU - Rumberger, John A.

AU - Budoff, Matthew J.

AU - Blumenthal, Roger S

PY - 2005/7

Y1 - 2005/7

N2 - Cardiovascular disease (CVD) is the leading cause of mortality in women and a major cause of morbidity. Coronary artery disease (CAD) accounts for nearly half of all CVD deaths. Traditional risk factors are very helpful in predicting the development of CAD in women; however, many women suffer events in the absence of established risk factors for atherosclerosis. To meet the challenge of CAD, several tools have been developed to identify atherosclerotic disease in its preclinical stages, with the hope of modifying its natural history. In this article, we review the current literature on utilization of electron beam tomography (EBT) for detection of CAD as a tool to conduct risk stratification in the general asymptomatic female population as well as among asymptomatic women. In conclusion, EBT can be used to estimate the overall coronary atherosclerotic plaque burden in women. It can also be used to diagnose its presence and determine its extent; furthermore, information from the coronary artery calcium scores can be used to assess the likelihood of obstructive disease and to provide prognostic information. Finally, EBT has the potential to determine the consequences of therapeutic interventions regarding progression, stabilization, or regression of coronary atherosclerotic disease.

AB - Cardiovascular disease (CVD) is the leading cause of mortality in women and a major cause of morbidity. Coronary artery disease (CAD) accounts for nearly half of all CVD deaths. Traditional risk factors are very helpful in predicting the development of CAD in women; however, many women suffer events in the absence of established risk factors for atherosclerosis. To meet the challenge of CAD, several tools have been developed to identify atherosclerotic disease in its preclinical stages, with the hope of modifying its natural history. In this article, we review the current literature on utilization of electron beam tomography (EBT) for detection of CAD as a tool to conduct risk stratification in the general asymptomatic female population as well as among asymptomatic women. In conclusion, EBT can be used to estimate the overall coronary atherosclerotic plaque burden in women. It can also be used to diagnose its presence and determine its extent; furthermore, information from the coronary artery calcium scores can be used to assess the likelihood of obstructive disease and to provide prognostic information. Finally, EBT has the potential to determine the consequences of therapeutic interventions regarding progression, stabilization, or regression of coronary atherosclerotic disease.

KW - Calcification

KW - Coronary artery disease

KW - Electron beam tomography

KW - Prevention

KW - Women

UR - http://www.scopus.com/inward/record.url?scp=20844440372&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20844440372&partnerID=8YFLogxK

U2 - 10.1097/01.crd.0000151371.92623.5c

DO - 10.1097/01.crd.0000151371.92623.5c

M3 - Article

VL - 13

SP - 174

EP - 183

JO - Cardiology in Review

JF - Cardiology in Review

SN - 1061-5377

IS - 4

ER -